Apeloa
Apeloa (普洛) , part of Hengdian Group (横店集团), is a top 5 pharmaceutical CDMO in China. Apeloa has been engaged in CDMO for over 20 years currently with 8 manufacturing sites and over 7,400 employees. The R&D centers are located in Boston, Shanghai, and Hengdian with a staff of over 600. The R&D capabilities include flow chemistry, synthetic biology, particle engineering, PROTAC, peptide, and ADC. Apeloa has the largest manufacturing capacity among the top 5 CDMOs in China. Apeloa has been inspected by USD FDA 18 times since 2006.
